5132-82-1 Usage
Description
9-(Methoxycarbonyl)-10-methylacridinium Methyl Sulfate, with the CAS number 5132-82-1, is a yellow solid compound that is primarily utilized in the field of organic synthesis. Its unique chemical structure and properties make it a valuable component in the creation of various organic compounds.
Uses
Used in Organic Synthesis:
9-(Methoxycarbonyl)-10-methylacridinium Methyl Sulfate is used as a synthetic building block for the development of new organic compounds. Its application in this field is due to its ability to participate in various chemical reactions, such as substitution, addition, and condensation, which are essential for the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 9-(Methoxycarbonyl)-10-methylacridinium Methyl Sulfate is used as an intermediate in the synthesis of various drugs. Its unique chemical properties allow it to be a key component in the development of new medications, potentially contributing to the treatment of various diseases and conditions.
Used in Chemical Research:
9-(Methoxycarbonyl)-10-methylacridinium Methyl Sulfate is also used in chemical research as a model compound to study the properties and reactivity of similar acridinium-based compounds. This helps researchers gain a deeper understanding of the structure-activity relationships and the potential applications of these compounds in various fields.
Used in Dye and Pigment Industry:
9-(Methoxycarbonyl)-10-methylacridinium Methyl Sulfate's yellow solid form makes it a potential candidate for use in the dye and pigment industry. 9-(Methoxycarbonyl)-10-methylacridinium Methyl Sulfate can be employed as a colorant in the production of various products, such as paints, inks, and plastics, due to its distinct color properties.
Check Digit Verification of cas no
The CAS Registry Mumber 5132-82-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,1,3 and 2 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 5132-82:
(6*5)+(5*1)+(4*3)+(3*2)+(2*8)+(1*2)=71
71 % 10 = 1
So 5132-82-1 is a valid CAS Registry Number.
5132-82-1Relevant articles and documents
Structure, formation, thermodynamics and interactions in 9-carboxy-10-methylacridinium-based molecular systems
Trzybiński, Damian,Zadykowicz, Beata,Wera, Micha?,Serdiuk, Illia E.,Sieradzan, Andrzej,Sikorski, Artur,Storoniak, Piotr,Krzymiński, Karol
, p. 7359 - 7372 (2016/09/12)
9-Carboxy-10-methylacridinium chloride and trifluoromethanesulfonate, the parent compounds for a wide range of chemiluminogenic salts of practical importance, were synthesized and thoroughly investigated to address problems concerning structural and thermodynamical issues of these cognitively interesting molecular systems. Under various conditions of crystallization, the title salts disclosed three types of crystals: one built from the monomeric form of cations and two containing homoconjugated cations. The title compounds made the first described derivatives of acridine, expressing homoconjugated cationic forms, both in crystalline solid and gaseous phases. The monocrystals were characterized, employing X-ray crystallography and spectroscopic methods such as MALDI-TOF MS, ESI-QTOF MS, NMR and UV-Vis. X-ray crystallography studies revealed the occurrence of the three different molecular architectures, in which not only the counter ions and stoichiometry are different, but also the space group and number of molecules in the unit cell. The energetics and intermolecular interactions occurring within the crystals were explored, applying crystal lattice energy calculations and Hirshfeld surface analysis. In order to elucidate the thermodynamics and origin of the experimentally revealed forms, computations based on the density functional theory were performed, assuming vapour and liquid phases.
10-Aminoalkyl 5H-dibenzo[b,f]azepines. Synthesis and antidepressive activities
Allais,Guillaume,Poittevin,et al.
, p. 371 - 381 (2007/10/02)
-
